Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Clinical trial NCT00064727 · COMPLETED
Trial details
- NCT number
- NCT00064727
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-09
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.